Abstract
The present research focuses on the molecular docking analysis of the isolated compound from the seaweed “Sargassum wightii” on cancer specific HER2 or HER2/neu also known as CD340. The ethanol derived compounds capable of binding to HER2 receptor is implicated for the breast cancer. The crystal structure of the HER2 protein with the resolution of 1.63Ao (Pdb entry 4RJ3) collected from the pdb website (www.pdb). Missing alignments and the side chains are prepared to fit for the insilico analysis. Seven bioactive compounds isolated from the hydro-alcoholic mixture using GC-MS are docked against HER2 using Schrodinger 2013.1 (Glide version 5.9). The binding sites, glide score and the energy of the 7 compounds with the HER2 protein are compared. The isolated compounds with most negative glide score such as benzoic acid, 2-hydroxy-ethyl ester, methyl salicylate, diethyl phthalate and phytol exhibited efficient in inhibiting the HER2 receptor of breast cancer. The Pharmacokinetics and Pharmacodynamics (ADME) properties of the selected highest glide scored compounds are performed using QikProp 3.6 module from Schrodinger-Maestro software. The compounds were showed significant ADME properties in basic criteria of Molecular weight (MW), H-Bond donor, H-Bond acceptor and log P (O/W). The results of the study showed that the compounds of “Sargassum wightii” may be a good target for breast Cancer.
Keywords: HER2/neu, Sargassum wightii, breast cancer, Schrodinger maestro, in-Silico analysis and QikProp.
The Natural Products Journal
Title:Screening of Potential Anticancer Compounds from Sargassum wightii to Target Breast Cancer Specific HER2 Receptor using in-silico Analysis
Volume: 6 Issue: 2
Author(s): P. Balachandran, T. V. Ajay Kumar and V. Parthasarathy
Affiliation:
Keywords: HER2/neu, Sargassum wightii, breast cancer, Schrodinger maestro, in-Silico analysis and QikProp.
Abstract: The present research focuses on the molecular docking analysis of the isolated compound from the seaweed “Sargassum wightii” on cancer specific HER2 or HER2/neu also known as CD340. The ethanol derived compounds capable of binding to HER2 receptor is implicated for the breast cancer. The crystal structure of the HER2 protein with the resolution of 1.63Ao (Pdb entry 4RJ3) collected from the pdb website (www.pdb). Missing alignments and the side chains are prepared to fit for the insilico analysis. Seven bioactive compounds isolated from the hydro-alcoholic mixture using GC-MS are docked against HER2 using Schrodinger 2013.1 (Glide version 5.9). The binding sites, glide score and the energy of the 7 compounds with the HER2 protein are compared. The isolated compounds with most negative glide score such as benzoic acid, 2-hydroxy-ethyl ester, methyl salicylate, diethyl phthalate and phytol exhibited efficient in inhibiting the HER2 receptor of breast cancer. The Pharmacokinetics and Pharmacodynamics (ADME) properties of the selected highest glide scored compounds are performed using QikProp 3.6 module from Schrodinger-Maestro software. The compounds were showed significant ADME properties in basic criteria of Molecular weight (MW), H-Bond donor, H-Bond acceptor and log P (O/W). The results of the study showed that the compounds of “Sargassum wightii” may be a good target for breast Cancer.
Export Options
About this article
Cite this article as:
Balachandran P., V. Ajay Kumar T. and Parthasarathy V., Screening of Potential Anticancer Compounds from Sargassum wightii to Target Breast Cancer Specific HER2 Receptor using in-silico Analysis, The Natural Products Journal 2016; 6 (2) . https://dx.doi.org/10.2174/2210315506666160218224112
DOI https://dx.doi.org/10.2174/2210315506666160218224112 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemoprevention Gene Therapy (CGT): Novel Combinatorial Approach for Preventing and Treating Pancreatic Cancer
Current Molecular Medicine The Pathophysiological Role of PEDF in Bone Diseases
Current Molecular Medicine Advances and Recent Self-Assembled Patented Structures for Breast Cancer Therapy
Recent Patents on Materials Science Label-Free Cell Phenotypic Drug Discovery
Combinatorial Chemistry & High Throughput Screening Nutrigenomics: Advances, Opportunities and Challenges in Understanding the Nutrient-Gene Interactions
Current Nutrition & Food Science The Prevalence of Frailty in Patients Admitted to Hospital with Vertebral Fragility Fractures
Current Rheumatology Reviews Therapeutic Targeting of Developmental Signaling Pathways in Medulloblastoma: Hedgehog, Notch, Wnt and Myc
Current Signal Transduction Therapy Strategies for Conjugation of Biomolecules to Nanoparticles as Tumor Targeting Agents
Current Pharmaceutical Design Chronic Inflammation and Oxidative Stress as a Major Cause of Age- Related Diseases and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery Meet Our Editorial Board Member
Current Gene Therapy Base Excision Repair: Contribution to Tumorigenesis and Target in Anticancer Treatment Paradigms
Current Medicinal Chemistry Study of Parasitic Infections, Cancer, and other Diseases with Mass-Spectrometry and Quantitative Proteome-Disease Relationships
Current Proteomics NOTCH Signaling as a Novel Cancer Therapeutic Target
Current Cancer Drug Targets Survivin Modulators: An Updated Patent Review (2011 - 2015)
Recent Patents on Anti-Cancer Drug Discovery Ozone Dosage Effect on C6 Cell Growth: in Vitro and in Vivo Tests
Anti-Cancer Agents in Medicinal Chemistry Can PPARγ Ligands Be Used in Cancer Therapy?
Current Medicinal Chemistry - Anti-Cancer Agents Garcinia Benzophenones Inhibit the Growth of Human Colon Cancer Cells and Synergize with Sulindac Sulfide and Turmeric
Anti-Cancer Agents in Medicinal Chemistry Targeting the Role of Astrocytes in the Progression of Alzheimers Disease
Current Signal Transduction Therapy Regulation of HIPK Proteins by MicroRNAs
MicroRNA Editorial [ Hot Topic: Targeting Tumor Angiogenesis: An Update (Guest Editor: Girolamo Ranieri)]
Current Medicinal Chemistry